Screening for celiac disease in the general population and in high-risk groups

Jonas F. Ludvigsson, Timothy R. Card, Katri Kaukinen, Julio Bai, Fabiana Zingone, David S. Sanders, Joseph A Murray

Research output: Contribution to journalReview article

51 Citations (Scopus)

Abstract

Background: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. Conclusions: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups.

Original languageEnglish (US)
Pages (from-to)106-120
Number of pages15
JournalUnited European Gastroenterology Journal
Volume3
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Celiac Disease
Mass Screening
Population
Quality of Life
Asymptomatic Diseases
PubMed
Publications
Comorbidity
Costs and Cost Analysis
Therapeutics

Keywords

  • Celiac disease
  • Gluten
  • Gluten-free diet
  • Prevention
  • Quality of life
  • Review
  • Risk
  • Screening
  • World health organization

ASJC Scopus subject areas

  • Gastroenterology
  • Oncology

Cite this

Screening for celiac disease in the general population and in high-risk groups. / Ludvigsson, Jonas F.; Card, Timothy R.; Kaukinen, Katri; Bai, Julio; Zingone, Fabiana; Sanders, David S.; Murray, Joseph A.

In: United European Gastroenterology Journal, Vol. 3, No. 2, 2015, p. 106-120.

Research output: Contribution to journalReview article

Ludvigsson, Jonas F. ; Card, Timothy R. ; Kaukinen, Katri ; Bai, Julio ; Zingone, Fabiana ; Sanders, David S. ; Murray, Joseph A. / Screening for celiac disease in the general population and in high-risk groups. In: United European Gastroenterology Journal. 2015 ; Vol. 3, No. 2. pp. 106-120.
@article{b5572b28a4364161b2d4d1139c2cc298,
title = "Screening for celiac disease in the general population and in high-risk groups",
abstract = "Background: Celiac disease (CD) occurs in approximately 1{\%} of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. Conclusions: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups.",
keywords = "Celiac disease, Gluten, Gluten-free diet, Prevention, Quality of life, Review, Risk, Screening, World health organization",
author = "Ludvigsson, {Jonas F.} and Card, {Timothy R.} and Katri Kaukinen and Julio Bai and Fabiana Zingone and Sanders, {David S.} and Murray, {Joseph A}",
year = "2015",
doi = "10.1177/2050640614561668",
language = "English (US)",
volume = "3",
pages = "106--120",
journal = "United European Gastroenterology Journal",
issn = "2050-6406",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Screening for celiac disease in the general population and in high-risk groups

AU - Ludvigsson, Jonas F.

AU - Card, Timothy R.

AU - Kaukinen, Katri

AU - Bai, Julio

AU - Zingone, Fabiana

AU - Sanders, David S.

AU - Murray, Joseph A

PY - 2015

Y1 - 2015

N2 - Background: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. Conclusions: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups.

AB - Background: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. Conclusions: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups.

KW - Celiac disease

KW - Gluten

KW - Gluten-free diet

KW - Prevention

KW - Quality of life

KW - Review

KW - Risk

KW - Screening

KW - World health organization

UR - http://www.scopus.com/inward/record.url?scp=84981194134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981194134&partnerID=8YFLogxK

U2 - 10.1177/2050640614561668

DO - 10.1177/2050640614561668

M3 - Review article

AN - SCOPUS:84981194134

VL - 3

SP - 106

EP - 120

JO - United European Gastroenterology Journal

JF - United European Gastroenterology Journal

SN - 2050-6406

IS - 2

ER -